- Home
- PROK vs WETO Comparison
PROK vs WETO Comparison
Compare PROK & WETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- WETO
- Stock Information
- Founded
- PROK 2015
- WETO 2019
- Country
- PROK United States
- WETO China
- Employees
- PROK N/A
- WETO N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- WETO
- Sector
- PROK Health Care
- WETO
- Exchange
- PROK Nasdaq
- WETO NYSE
- Market Cap
- PROK 94.9M
- WETO 88.0M
- IPO Year
- PROK N/A
- WETO 2025
- Fundamental
- Price
- PROK $0.98
- WETO $2.62
- Analyst Decision
- PROK Buy
- WETO
- Analyst Count
- PROK 4
- WETO 0
- Target Price
- PROK $5.00
- WETO N/A
- AVG Volume (30 Days)
- PROK 522.0K
- WETO 2.1M
- Earning Date
- PROK 05-12-2025
- WETO 01-01-0001
- Dividend Yield
- PROK N/A
- WETO N/A
- EPS Growth
- PROK N/A
- WETO N/A
- EPS
- PROK N/A
- WETO N/A
- Revenue
- PROK $306,000.00
- WETO $5,350,773.00
- Revenue This Year
- PROK $54.34
- WETO N/A
- Revenue Next Year
- PROK N/A
- WETO N/A
- P/E Ratio
- PROK N/A
- WETO N/A
- Revenue Growth
- PROK N/A
- WETO N/A
- 52 Week Low
- PROK $0.46
- WETO $1.50
- 52 Week High
- PROK $3.43
- WETO $4.30
- Technical
- Relative Strength Index (RSI)
- PROK 65.88
- WETO N/A
- Support Level
- PROK $0.75
- WETO N/A
- Resistance Level
- PROK $0.82
- WETO N/A
- Average True Range (ATR)
- PROK 0.07
- WETO 0.00
- MACD
- PROK 0.03
- WETO 0.00
- Stochastic Oscillator
- PROK 88.17
- WETO 0.00
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About WETO WEBUS INTERNATIONAL LIMITED
Webus International Ltd operates on a business model of Mobility-as-a-Service to identify and solve inefficiencies associated with inflexible or low-quality public transportation and provide cost-efficient and customized mass transportation services under different scenarios with comprehensive digital platforms. It offers commute shuttle service, customized chartered bus service, packaged tour service and other service to customers.